Filing Details

Accession Number:
0001628280-21-001393
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-03 16:50:32
Reporting Period:
2021-02-01
Accepted Time:
2021-02-03 16:50:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
727207 Accelerate Diagnostics Inc AXDX Laboratory Analytical Instruments (3826) 841072256
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1784805 Jack Phillips C/O Accelerate Diagnostics, Inc.
3950 S. Country Club Road, Suite 470
Tucson AZ 85714
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-01 10,000 $0.00 13,821 No 4 M Direct
Common Stock Disposition 2021-02-02 3,313 $10.90 10,508 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Restricted Stock Units Disposition 2021-02-01 10,000 $0.00 10,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 No 4 M Direct
Footnotes
  1. Shares sold solely to pay taxes due upon the vesting of restricted stock units.
  2. Each restricted stock unit represents a contingent right to receive one share of common stock of Accelerate Diagnostics, Inc. (the "Issuer").
  3. On February 1, 2020, the reporting person was granted restricted stock units, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. Upon vesting, the reporting person will receive such number of shares of the Issuer's common stock equal to the number of restricted stock units that vested.
  4. Not applicable.